PSS232

an mGlu5 receptor radioligand; structure in first source

Also Known As:

(18F)PSS232; 3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-(18F)-fluoroethoxy)propyl)oxime; 3-(pyridin-2-ylethynyl)cyclohex-2-enone O-(3-(2-fluoroethoxy)propyl)oxime

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Hydroxylamines: 16
    - Oximes: 1292
      - PSS232: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - PSS232: 1

Experts

1.	Adamantidis, Antoine: 1 article (11/2019)
2.	Ametamey, Simon M: 1 article (11/2019)
3.	Hasler, Gregor: 1 article (11/2019)
4.	Krämer, Stefanie D: 1 article (11/2019)
5.	Mihov, Yoan: 1 article (11/2019)
6.	Mu, Linjing: 1 article (11/2019)
7.	Müller Herde, Adrienne: 1 article (11/2019)

Related Diseases

1.	Tobacco Use Disorder (Nicotine Dependence) 11/01/2019 - "As human PET data either reflect the impact of chronic nicotine exposure or a pre-existing vulnerability to nicotine addiction, we designed a preclinical, longitudinal study to investigate the effect of chronic nicotine exposure on mGluR5 with the novel radiotracer [18F]PSS232 using PET. "

Related Drugs and Biologics

1.	Nicotine